These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 18635712)
1. Positive interference of the analgesic nefopam in the urine immunoassay for benzodiazepines in a secure setting. Reid KS J Psychopharmacol; 2009 Nov; 23(8):997. PubMed ID: 18635712 [TBL] [Abstract][Full Text] [Related]
3. Nefopam and ketoprofen synergy in rodent models of antinociception. Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069 [TBL] [Abstract][Full Text] [Related]
4. Long-term pain vulnerability after surgery in rats: prevention by nefopam, an analgesic with antihyperalgesic properties. Laboureyras E; Chateauraynaud J; Richebé P; Simonnet G Anesth Analg; 2009 Aug; 109(2):623-31. PubMed ID: 19608840 [TBL] [Abstract][Full Text] [Related]
5. A Simultaneous Mixed-Effects Pharmacokinetic Model for Nefopam, N-desmethylnefopam, and Nefopam N-Oxide in Human Plasma and Urine. Mittur A Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):391-404. PubMed ID: 29305813 [TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity of nefopam and its metabolites with benzodiazepine EMIT immunoassay. El-Haj B; Al-Amri A; Ali H J Anal Toxicol; 2008; 32(9):790-2. PubMed ID: 19021938 [No Abstract] [Full Text] [Related]
7. [Analgesic effect of continuous intravenous nefopam after urological surgery]. Merle JC; Vandroux D; Odin I; Dupuis JL; Bougault A; Mehaddi Y; Nathan N Ann Fr Anesth Reanim; 2005 Jan; 24(1):13-8. PubMed ID: 15661459 [TBL] [Abstract][Full Text] [Related]
8. Effect of route of administration on the pharmacokinetic behavior of enantiomers of nefopam and desmethylnefopam. Chawla J; Le Guern ME; Alquier C; Kalhorn TF; Levy RH Ther Drug Monit; 2003 Apr; 25(2):203-10. PubMed ID: 12657915 [TBL] [Abstract][Full Text] [Related]
10. Nefopam enantiomers: preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administration. Mather GG; Labroo R; Le Guern ME; Lepage F; Gillardin JM; Levy RH Chirality; 2000 Mar; 12(3):153-9. PubMed ID: 10689295 [TBL] [Abstract][Full Text] [Related]
11. Nefopam is more potent than carbamazepine for neuroprotection against veratridine in vitro and has anticonvulsant properties against both electrical and chemical stimulation. Novelli A; Groppetti A; Rossoni G; Manfredi B; Ferrero-Gutiérrez A; Pérez-Gómez A; Desogus CM; Fernández-Sánchez MT Amino Acids; 2007; 32(3):323-32. PubMed ID: 17021653 [TBL] [Abstract][Full Text] [Related]
12. Role of the histamine system in nefopam-induced antinociception in mice. Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297 [TBL] [Abstract][Full Text] [Related]
13. Adverse reactions associated with nefopam. Pillans PI; Woods DJ N Z Med J; 1995 Sep; 108(1008):382-4. PubMed ID: 7566787 [TBL] [Abstract][Full Text] [Related]
14. Double-blind clinical trial of nefopam in comparison with pentazocine in surgical patients. Pandit PN; Oke VG; Jha RJ; Bowalekar SK; Raghu CN Br J Clin Pract; 1989 Jun; 43(6):209-14. PubMed ID: 2597600 [TBL] [Abstract][Full Text] [Related]
15. Postoperative analgesia and early rehabilitation after total knee replacement: a comparison of continuous low-dose intravenous ketamine versus nefopam. Aveline C; Gautier JF; Vautier P; Cognet F; Hetet HL; Attali JY; Leconte V; Leborgne P; Bonnet F Eur J Pain; 2009 Jul; 13(6):613-9. PubMed ID: 18793861 [TBL] [Abstract][Full Text] [Related]
16. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database. Durrieu G; Olivier P; Bagheri H; Montastruc JL; Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209 [TBL] [Abstract][Full Text] [Related]
17. [Nefopam by continuous intravenous injection and adverse drug reactions: which causality assessment?]. Ould-Ahmed M; Drouillard I; El-Kartouti A; Wey PF; Lions C; Martinez JY Ann Fr Anesth Reanim; 2007 Jan; 26(1):74-6. PubMed ID: 17158020 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France). Labat L; Fontaine B; Delzenne C; Doublet A; Marek MC; Tellier D; Tonneau M; Lhermitte M; Frimat P Forensic Sci Int; 2008 Jan; 174(2-3):90-4. PubMed ID: 17418990 [TBL] [Abstract][Full Text] [Related]